. Moreover, by integrating multiple aptamer-MB probes (targeting HER2, MUC1, and GPC3) with machine learning, a sensor array is constructed to classify different cancer types and distinguish liver cancer patients from those with hepatitis and healthy individuals, demonstrating the clinical potential of this assay for noninvasive diagnosis.
Ma et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: